-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Exelixis, Raises Price Target to $52

Benzinga·07/02/2026 12:56:30
Listen to the news
UBS analyst Ashwani Verma maintains Exelixis (NASDAQ:EXEL) with a Neutral and raises the price target from $43 to $52.